Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD : revenue, balance sheet and financial ratios

SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD is a French company founded 8 years ago, specialized in the sector Supports juridiques de gestion de patrimoine immobilier. Based in VINEUIL (41350), this company of category PME shows in 2024 a net income positive of 119 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD (SIREN 833808876)
Indicator 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 119 478 € 96 683 € 9 236 € 39 446 € 41 282 € 37 089 € -58 998 €
EBITDA -2 631 € -3 407 € -30 116 € -2 220 € -1 785 € -2 015 € -53 575 €
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD generates positive net income of 119 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 631 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-2 747 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

119 478 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 312%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 7.4 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

311.927%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

24.255%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

7.446

Solvency indicators evolution
SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD

Sector positioning

Debt ratio
311.93 2024
2022
2023
2024
Q1: 0.0
Med: 6.93
Q3: 134.27
Average

In 2024, the debt ratio of SPFPL DE PHARMACIEN D'OFF... (311.93) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
24.25% 2024
2022
2023
2024
Q1: 0.05%
Med: 26.57%
Q3: 74.17%
Average +20 pts over 3 years

In 2024, the financial autonomy of SPFPL DE PHARMACIEN D'OFF... (24.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
7.45 years 2024
2022
2023
2024
Q1: -1.34 years
Med: 0.0 years
Q3: 4.54 years
Watch

In 2024, the repayment capacity of SPFPL DE PHARMACIEN D'OFF... (7.45) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 2125.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

2125.34

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-232.079

Liquidity indicators evolution
SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD

Sector positioning

Liquidity ratio
2125.34 2024
2022
2023
2024
Q1: 94.1
Med: 322.17
Q3: 1824.83
Excellent +9 pts over 3 years

In 2024, the liquidity ratio of SPFPL DE PHARMACIEN D'OFF... (2125.34) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-232.08x 2024
2022
2023
2024
Q1: -25.66x
Med: 0.0x
Q3: 8.44x
Average

In 2024, the interest coverage of SPFPL DE PHARMACIEN D'OFF... (-232.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 117 days. Excellent situation: suppliers finance 117 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

117 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD

Positioning of SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD in its sector

Comparison with sector Supports juridiques de gestion de patrimoine immobilier

Valuation estimate

Based on 277 transactions of similar company sales (all years), the value of SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD is estimated at 266 609 € (range 59 915€ - 820 864€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
277 transactions
59k€ 266k€ 820k€
266 609 € Range: 59 915€ - 820 864€
NAF 5 all-time

Valuation method used

Net Income Multiple
119 478 € × 2.2x = 266 609 €
Range: 59 916€ - 820 864€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Supports juridiques de gestion de patrimoine immobilier)

Compare SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD with other companies in the same sector:

Voir toutes les statistiques du secteur Supports juridiques de gestion de patrimoine immobilier

Frequently asked questions about SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD

What is the revenue of SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD ?

The revenue of SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD profitable?

Yes, SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD generated a net profit of 119 k€ in 2024.

Where is the headquarters of SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD ?

The headquarters of SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD is located in VINEUIL (41350), in the department Loir-et-Cher.

Where to find the tax return of SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD ?

The tax return of SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD operate?

SPFPL DE PHARMACIEN D'OFFICINE FLORENCE GALLARD operates in the sector Supports juridiques de gestion de patrimoine immobilier (NAF code 68.32B). See the 'Sector positioning' section above to compare the company with its competitors.